US Stock MarketDetailed Quotes

CRXTQ CLARUS THERAPEUTICS HLDGS INC

Watchlist
  • 0.001
  • 0.0000.00%
15min DelayClose Mar 1 16:00 ET
72.83KMarket Cap0.00P/E (TTM)

About CLARUS THERAPEUTICS HLDGS INC Company

Clarus Therapeutics Holdings Inc is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. The company is focused on focused on the commercialization of JATENZO (testosterone undecanoate), the first and only oral testosterone replacement, or testosterone replacement therapy, and JATENZO is the sole source of company's revenue.

Company Profile

SymbolCRXTQ
Company NameCLARUS THERAPEUTICS HLDGS INC
CEODr. Robert E. Dudley
MarketPink Market
Employees16
Fiscal Year Ends12-31
Websitehttps://www.clarustherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Robert E. Dudley
  • Director, President and Chief Executive Officer
  • --
  • Steven A. Bourne
  • Chief Administrative Officer, Secretary and Treasurer
  • --
  • Frank Jaeger
  • Chief Commercial Officer
  • --
  • Richard D. Peterson
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Kimberly M. Murphy
  • Chairman of the Board
  • --
  • Mark A. Prygocki, Sr
  • Independent Director
  • --
  • John Kenneth Amory
  • Independent Director
  • --
  • Elizabeth A. Cermak
  • Independent Director
  • --
  • Alex Zisson
  • Independent Director
  • --
Trending US Stocks
Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Symbol Mini Chart % Chg
Moody's
MCO
+1.75%
Coca-Cola
KO
+1.43%
VeriSign
VRSN
+1.17%
MasterCard
MA
+0.98%
DaVita
DVA
+0.83%

Unlock the Full List